T

Trevena

D
TRVN
USD
-0.175
(-3.4688%)
Market Closed
83.000
Volume
-32.25
EPS
-
Div Yield
-0.086195
P/E
4,153,783.71
Market Cap
Today
-3.4688%
1 Week
-26.987%
1 Month
2.526%
6 Months
-64.755%
12 Months
-72.167%
Year To Date
-73.001%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
A
ADMP
(%)
USD
A
ACER
(%)
USD
A
ACRX
(%)
USD
A
AGRX
(%)
USD
A
ALKS
0.52
(1.8671%)
USD
A
ALNY
3.06
(1.1203%)
USD
A
ARDX
0.085
(1.4382%)
USD
A
ASRT
0.045
(3.4483%)
USD
A
AUPH
0.125
(1.768%)
USD

Title:
Trevena Inc

Sector:
Healthcare
Industry:
Biotechnology
Trevena Inc is an American biopharmaceutical company focused on developing and commercializing novel medicines for patients affected by central nervous system, or CNS, disorders.
Do you need help or have a question?
Contact Us